Candriam SCA’s Match Group MTCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-30,008
Closed -$1.06M 814
2023
Q1
$1.06M Buy
30,008
+902
+3% +$39.3K 0.01% 692
2022
Q4
$1.21M Sell
29,106
-19,300
-40% -$873K 0.01% 669
2022
Q3
$2.31M Buy
48,406
+33,354
+222% +$2.1M 0.02% 561
2022
Q2
$1.05M Hold
15,052
0.01% 617
2022
Q1
$1.64M Buy
15,052
+944
+7% +$104K 0.01% 583
2021
Q4
$1.87M Buy
14,108
+728
+5% +$105K 0.01% 560
2021
Q3
$2.1M Buy
13,380
+345
+3% +$52.5K 0.01% 569
2021
Q2
$2.1M Buy
13,035
+381
+3% +$55.8K 0.01% 575
2021
Q1
$1.84M Hold
12,654
0.02% 532
2020
Q4
$1.91M Buy
12,654
+991
+8% +$131K 0.02% 544
2020
Q3
$1.29M Buy
+11,663
New +$1.24M 0.01% 572

Other funds holding MTCH

Candriam SCA's MTCH Position: Q2 2023 in Review

Candriam SCA sold out of Match Group (MTCH) in Q2 2023, closing a stake of 30,008 shares — an estimated $1.06M sold.

Candriam SCA first reported a position in MTCH in Q3 2020 and held it in 11 quarters. The position peaked at $2.31M in Q3 2022. 609 funds tracked by Wall St. Rank hold MTCH as of Q2 2023.

  • Candriam SCA reported no remaining Match Group position as of Q2 2023 after selling out during the quarter.
  • Candriam SCA sold 30,008 Match Group shares in Q2 2023, an estimated $1.06M.
  • Candriam SCA first reported a position in Match Group in Q3 2020 and held it in 11 quarters.
  • Candriam SCA's Match Group position peaked at $2.31M in Q3 2022.
  • 609 funds tracked by Wall St. Rank held Match Group as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.